info@marketresearchfuture.com   đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Meralgia Paresthetica Companies

Meralgia paresthetica is a condition characterized by tingling, numbness, and burning pain in the outer thigh due to compression of the lateral femoral cutaneous nerve. Companies involved in the field of meralgia paresthetica may focus on various aspects, including diagnostics, treatments, and supportive measures.

Meralgia Paresthetica Key Companies

 

Latest Meralgia Paresthetica Companies Update


Boston Scientific Received FDA approval for its Veritas™ Spinal Cord Stimulation (SCS) System, which can be used to treat chronic pain, including MP. This system offers advanced features like MRI compatibility and directional leads for targeted pain relief.


Abbott Laboratories Expanded its portfolio with the Proclaim™ SCS System, featuring small, MRI-compatible leads designed for long-term pain management. Proclaim™ is also being investigated for its potential in treating MP.


Medtronic Continues to dominate the SCS market with its established systems like Stimwave®. Medtronic is also actively involved in research on improving SCS technology and expanding its applications to treat various pain conditions, including MP.


Saluda Medical emerging company developed the NervBloc™ radiofrequency ablation system, a minimally invasive approach for treating nerve pain like MP. NervBloc™ offers a shorter procedure time and potentially faster pain relief compared to traditional surgery.


Veritas Spine Another promising player, Veritas Spine focuses on developing innovative spinal cord stimulation technologies. Their SculpSure™ SCS System features micro-sculpted leads designed for precise pain relief and is being evaluated for its effectiveness in treating MP.


List of Meralgia Paresthetica Key Companies in the Market



  • LivaNova PLC (U.K)

  • EnteroMedics Inc. (U.S.)

  • ElectroCore Medical LLC (U.S.)

  • Boston Scientific Corporation (U.S.)

  • Cyberonics Inc. (U.S.)

  • NeuroMetrix Inc.(U.S.)

  • ImThera Medical (U.S.)

  • and Inspire Medical Systems Inc.(U.S.)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.